PMU60 - IS TRANSPARENCY IN SLOVAK HTA EFFICIENT ENOUGHT? COMPARING PHARMACOECONOMICS METHODOLOGIES USED IN PRICING REIMBURSEMENT APPLICATIONS FOR INNOVATIVE THERAPIES TOWARDS REQUIREMENTS DEFINED BY THE LAW
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1896
https://www.valueinhealthjournal.com/article/S1098-3015(18)35198-2/fulltext
Title :
PMU60 - IS TRANSPARENCY IN SLOVAK HTA EFFICIENT ENOUGHT? COMPARING PHARMACOECONOMICS METHODOLOGIES USED IN PRICING REIMBURSEMENT APPLICATIONS FOR INNOVATIVE THERAPIES TOWARDS REQUIREMENTS DEFINED BY THE LAW
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35198-2&doi=10.1016/j.jval.2018.09.1896
First page :
Section Title :
Open access? :
No
Section Order :
1262